Israeli startup launches world’s first saliva-based pregnancy test

Salignostics, a Jerusalem-based medical startup, said it will sell the world’s first and only saliva-based rapid pregnancy test kit.

The cost-effective, rapid and non-invasive method of detecting pregnancy offers accurate results in minutes, the company said. SaliStick sales are scheduled to begin early next year.

Salignostics has successfully completed clinical trials in Israel in more than 300 women, both pregnant and non-pregnant, and has completed thousands of analytical trials. The company is in very advanced stages of receiving the European Union CE mark for Salistick and has completed an initial Q 510 (K) submission of the test kit to the FDA in the US, he said.

Saliva contains more than 5,000 identified proteins that reflect and overlap the physiological state of the blood, Salignostics said. Building on the same principles used to develop SaliCov, its rapid saliva antigen test kit for COVID-19, Salistick can detect the pregnancy hormone β-hCG in saliva and deliver proven and accurate detection rates for early pregnancy .

“Saliva is the key to a quick diagnosis for a variety of medical reasons. Essentially, it is the only non-invasive, easy and hygienic means of detecting hormones, viruses and even disease, ”said Dr. Guy Krief, Co-Founder and Deputy CEO of Salignostics. “With Salistick, we are taking advantage of the powerful diagnostic capabilities that we have been able to create by analyzing saliva. We are delivering a product that completely eliminates the need for blood and urine samples when performing pregnancy tests. “

The annual global market for pregnancy tests is estimated at more than $ 2 billion, with an estimated hundreds of millions of tests sold each year. Research by Salignostics shows that over 68% of the women surveyed would opt for a saliva-based test kit over traditional pregnancy screening tests.

The Salignostics COVID-19 Antigen Saliva Test Kit received a CE mark from the European Union for marketing throughout Europe, and is the only saliva-based rapid antigen COVID test included in the National Institute’s RADx accelerator program. To date, the company has provided hundreds of thousands of kits to Europe and Africa.

The SaliStick pregnancy test based on saliva. (credit: courtesy)

Results are derived exclusively from saliva analysis and are based on platform technology. As the technology is not biomarker specific, it can be replicated and used for multiple applications and use cases, for example COVID-19 and even malaria detection.

Salignostics was founded in 2016 at the Hadassah University Medical Center in Ein Kerem in Jerusalem by a group of five like-minded doctors who identified a growing need for a cost-effective means of monitoring health status, disease onset, progression and outcome of treatment through -invasive means.

“By cracking the code of saliva, we are helping advance the way medical professions can make diagnoses and empower people to make informed decisions about their own health and well-being,” said Krief.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *